Zerit and Elastosis perforans - a phase IV clinical study of FDA data
Summary:
We study 9,934 people who take Zerit (stavudine) or have Elastosis perforans. No report of Elastosis perforans is found in people who take Zerit.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Zerit?
Zerit has active ingredients of stavudine. eHealthMe is studying from 9,912 Zerit users. Check the latest studies of Zerit.
What is Elastosis Perforans?
Elastosis perforans (disorder of the connective tissue characterized by ring-shaped groups of symptom) is found to be associated with 3 drugs and 9 conditions by eHealthMe. Check the latest studies of Elastosis perforans.
No report is found.
Do you take Zerit and have Elastosis perforans?
- Check whether Elastosis perforans is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Zerit:
- Zerit (9,912 reports)
Elastosis perforans treatments and more:
- Elastosis perforans (22 reports)
How severe was Elastosis perforans and when was it recovered:
Expand to all the drugs that have ingredients of stavudine:
Browse all side effects of Zerit:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Elastosis perforans:
Browse all the conditions that are associated with Elastosis perforans:
How the study uses the data?
The study uses data from the FDA. It is based on stavudine (the active ingredients of Zerit) and Zerit (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Humalog cause Osteosclerosis? - 5 seconds ago
- Could Bisoprolol Fumarate cause Puncture Site Haemorrhage? - 5 seconds ago
- Could Copaxone cause Thrombocytopenia? - 8 seconds ago
- Could Amlodipine Besylate cause Myoclonus? - 8 seconds ago
- Could Synagis cause Overdose? - 16 seconds ago
- Drug interactions of Nystatin and Deltasone - 17 seconds ago
- Darvocet A500 vs. Tylenol W/ Codeine No. 3, side effect and effectiveness comparison - 23 seconds ago
- Depression and Hypochloraemia - 23 seconds ago
- How effective is Prednisone for Lupus-Like Syndrome? - 23 seconds ago
- Ibuprin vs. Neurontin, side effect and effectiveness comparison - 24 seconds ago